Gemmer Asset Management LLC - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 248 filers reported holding NEKTAR THERAPEUTICS in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.

Quarter-by-quarter ownership
Gemmer Asset Management LLC ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q4 2021$5,000
-44.4%
363
-27.0%
0.00%0.0%
Q3 2021$9,0000.0%4970.0%0.00%0.0%
Q2 2021$9,000
+50.0%
497
+67.3%
0.00%0.0%
Q1 2021$6,000
+20.0%
297
+8.4%
0.00%0.0%
Q4 2020$5,000
+25.0%
274
+5.0%
0.00%0.0%
Q3 2020$4,000
-33.3%
261
+5.7%
0.00%0.0%
Q2 2020$6,0000.0%247
-27.4%
0.00%
-50.0%
Q1 2020$6,000
-81.8%
340
-78.1%
0.00%
-75.0%
Q4 2019$33,000
+13.8%
1,550
-3.8%
0.01%
+14.3%
Q3 2019$29,000
-40.8%
1,611
+15.9%
0.01%
-46.2%
Q2 2019$49,000
+512.5%
1,390
+476.8%
0.01%
+550.0%
Q1 2019$8,0000.0%2410.0%0.00%0.0%
Q4 2018$8,000
-60.0%
241
-27.6%
0.00%
-66.7%
Q3 2018$20,000
-16.7%
333
-32.2%
0.01%
-25.0%
Q2 2018$24,000
-54.7%
491
-2.4%
0.01%
-55.6%
Q1 2018$53,000
+82.8%
503
+2.4%
0.02%
+80.0%
Q4 2017$29,000
+163.6%
491
+5.6%
0.01%
+150.0%
Q3 2017$11,000
+22.2%
4650.0%0.00%0.0%
Q2 2017$9,000
-18.2%
4650.0%0.00%
-20.0%
Q1 2017$11,000
+83.3%
4650.0%0.01%
+66.7%
Q4 2016$6,000
-25.0%
4650.0%0.00%
-25.0%
Q3 2016$8,000
+14.3%
4650.0%0.00%0.0%
Q2 2016$7,000
+40.0%
465
+16.5%
0.00%
+33.3%
Q1 2016$5,000
-76.2%
399
-68.6%
0.00%
-75.0%
Q4 2015$21,000
+950.0%
1,270
+513.5%
0.01%
+1100.0%
Q3 2015$2,0002070.00%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q4 2020
NameSharesValueWeighting ↓
Camber Capital Management LP 2,000,000$67,200,0003.35%
First Light Asset Management, LLC 763,403$25,650,0003.33%
BRIDGER MANAGEMENT, LLC 1,238,489$41,613,0003.29%
Rhenman & Partners Asset Management AB 734,445$24,677,0002.89%
BB BIOTECH AG 2,020,676$67,895,0001.71%
Gs Investments, Inc. 54,200$1,821,120,0001.43%
Artal Group S.A. 900,000$30,240,0001.24%
Cormorant Asset Management, LP 500,000$16,800,0001.14%
TOBAM 640,547$21,522,0001.09%
Bellevue Group AG 430,026$14,449,0000.80%
View complete list of NEKTAR THERAPEUTICS shareholders